Literature DB >> 14633144

Causes and consequences of kidney loss in patients with nephrolithiasis.

Elaine Worcester1, Joan H Parks, Michelle A Josephson, Ronald A Thisted, Fredric L Coe.   

Abstract

BACKGROUND: It is unknown whether stone formers may safely donate a kidney. Nephrectomy could accelerate stone formation, or loss of filtration with age. We contrast, here, the course of stone patients with two versus one kidney.
METHODS: One hundred fifteen patients with a single functioning kidney were compared with 3151 patients with two kidneys. Cause of kidney loss was determined, along with stone types, rates of stone formation, urine stone risk factors, and creatinine clearance.
RESULTS: Women were 49.6% of the patients with kidney loss, compared to 33.6% of ordinary stone formers. Obstruction, stone burden, and infection were the most common reasons for kidney loss. We found an increased number of struvite and calcium phosphate stones among single kidney patients. Before and during treatment, single kidney patients had fewer stones than ordinary stone formers. Creatinine clearance was lower in the single kidney patients; rate of loss of kidney function with age was higher among single kidney males versus two kidney males if all patients are considered. Among males >age 45 years, the difference disappears. Females with one and two kidneys lost function with age at equivalent rates. Compared with nonstone formers, male stone formers lose kidney function with age at an accelerated rate.
CONCLUSION: Nephrectomy does not worsen stone disease. It may increase loss of renal function among younger males. The pattern of renal function loss with age differs between stone formers and nonstone formers.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14633144     DOI: 10.1046/j.1523-1755.2003.00317.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  29 in total

1.  Nephrectomy as a cause of chronic kidney disease in the treatment of urolithiasis: a case-control study.

Authors:  Mauricio Carvalho; Rafael Luis Santos Martin; Rodrigo Coutinho Passos; Miguel Carlos Riella
Journal:  World J Urol       Date:  2012-02-29       Impact factor: 4.226

Review 2.  Acute and chronic kidney injury in nephrolithiasis.

Authors:  Xiaojing Tang; John C Lieske
Journal:  Curr Opin Nephrol Hypertens       Date:  2014-07       Impact factor: 2.894

Review 3.  Genetic determinants of urolithiasis.

Authors:  Carla G Monico; Dawn S Milliner
Journal:  Nat Rev Nephrol       Date:  2011-12-20       Impact factor: 28.314

Review 4.  Pitfalls in the management of patients with primary hyperoxaluria: a urologist's perspective.

Authors:  Vernon M Pais; Dean G Assimos
Journal:  Urol Res       Date:  2005-11-13

5.  Uric acid stones increase the risk of chronic kidney disease.

Authors:  Ching-Chia Li; Tsu-Ming Chien; Wen-Jeng Wu; Chun-Nung Huang; Yii-Her Chou
Journal:  Urolithiasis       Date:  2018-02-28       Impact factor: 3.436

Review 6.  Recent advances in the pathophysiology of nephrolithiasis.

Authors:  Khashayar Sakhaee
Journal:  Kidney Int       Date:  2008-12-10       Impact factor: 10.612

7.  Association of estimated glomerular filtration rate with 24-h urinalysis and stone composition.

Authors:  Daniel M Moreira; Justin I Friedlander; Christopher Hartman; Boris Gershman; Arthur D Smith; Zeph Okeke
Journal:  Urolithiasis       Date:  2015-11-16       Impact factor: 3.436

8.  Urolithiasis and the risk of ESRD.

Authors:  Ziad M El-Zoghby; John C Lieske; Robert N Foley; Eric J Bergstralh; Xujian Li; L Joseph Melton; Amy E Krambeck; Andrew D Rule
Journal:  Clin J Am Soc Nephrol       Date:  2012-06-28       Impact factor: 8.237

Review 9.  Pharmacology of stone disease.

Authors:  Khashayar Sakhaee
Journal:  Adv Chronic Kidney Dis       Date:  2009-01       Impact factor: 3.620

10.  Marginal kidney donor.

Authors:  Ganesh Gopalakrishnan; Siva Prasad Gourabathini
Journal:  Indian J Urol       Date:  2007-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.